A quantitative imaging platform for everything from Breast Cancer to Heart Disease51-200 Employees
- B2B
- Early StageStartup in initial stages
CureMetrix Funding
$3M
11 round
EvoNexus
CureMetrix is active in the following markets / industries: health care, medical devices, diagnostics and bioinformatics. The company has secured funding across 1 rounds, totaling in an amount of $3M. Their most recent funding was raised on July 29, 2016.
Investors of CureMetrix
Keshif Ventures
Early-Stage Seed Investing in Data Science, AI and Web3 companies in San Diego
Rounds
S
EvoNexus
Dr. Scott Worman
Ty Kalklosch
Founder and CRO PayLease, Entrepeneur, Investor
Dr. Dennis Sarabi
Steve Rosetta
Gregory M. McKee
Matt Seefeld
La Costa Investment Group
Rounds
S